ABSTRACT
OBJECTIVE: To determine the prevalence of depression in Filipino adult patients with type 2 diabetes mellitus (DM) and the risk factors associated in its development.METHODS:This is a prospective cross-sectional study. Adult patients (age 19 and above) with type 2 DM being seen at the outpatient department of the Makati Medical Center from January to March 2015 were included, taking into account the following: age, gender, marital status, body mass index, waist circumference, blood pressure, duration of diabetes, presence of other co-morbid illnesses, pill burden, insulin use, educational attainment, employment status, family income, and glycemic status. They were then screened for depression using the standardized PHQ-9 questionnaire. Bivariate analyses through Chi-square Test (for categorical variables) and Analysis of Variance (for interval/ratio variables) were used to determine which among the risk factors are significant for the development of depression.Significant risk factors were treated for multivariate and univariate analyses through ordinal logistic regression.RESULTS: A total of 110 adult patients with type 2 DM were enrolled in this study. There were no drop-outs. Sixty-nine percent of the patients had none to minimal depression, 24% had mild depression, and 7% had moderate depression. None of the patients had depression that warranted anti-depressants or psychotherapy.After step-wise analysis, increased BMI, elevated diastolic blood pressure and uncontrolled blood sugar were found to be associated with higher PHQ-9 scores while unemployment was associated with decreased PHQ-9 score.CONCLUSION:The prevalence of depression among Filipino type 2 diabetic patients is higher than in non-diabetic patients. Being obese, having an elevated diastolic blood pressure, and the presence of uncontrolled blood sugar were significant predictors and were associated with an increased likelihood of developing major depressive disorder. Being unemployed appears to have the opposite effect.
Subject(s)
Humans , Male , Female , Young Adult , Adolescent , Blood Glucose , Diabetes Mellitus, Type 2 , Depression , Depressive Disorder, Major , Insulin , Risk Factors , Waist Circumference , Comorbidity , EndocrinologyABSTRACT
INTRODUCTION: Pre-impaired glucose tolerance (pre-IGT) or compensated hyperinsulinemia, is defined as normal glucose, and elevated insulin two hours after a 75-gram oral glucose load. It is characteristic of the early stages of diabetes mellitus (DM), where beta cells compensate for insulin resistance by increasing insulin secretion to maintain normoglycemia. With continuing beta cell failure, insulin secretion eventually fails, leading to the progression to diabetes. Nonalcoholic fatty liver disease (NAFLD), a common feature of insulin resistance, is found in 50-75% and 42-55% of DM and pre-diabetes patients. We determined if NAFLD was present in patients with pre-IGT.METHOD: A study on the determination of NAFLD - diagnosed by liver ultrasound in pre-IGT patients at a university hospital.Descriptive statistics, Chi square test of independence, 2x2 Fischer Exact test, Z test of difference in proportion, were used for statistical analysis with a p-value set at 0.05?.IBMSPSS ver 21 was used as software.RESULTS:The mean age of 22 patients was 29.95 years, with average BMI of 25.73 kg/m2;77.3% were female. Average lipid panels were within optimal limits; kidney and liver functions were normal. The mean insulin level was 58.36 uIU/mL. NAFLD was identified in eight of the subjects. CONCLUSION: Although pre-IGT is a subclinical phase in the diabetes spectrum, 36% already have NAFLD.This prevalence was lower compared to diabetics and pre-diabetics, but higher compared to the general population.There was a noticeable trend of increasing insulin levels with increasing severity of fatty liver.
Subject(s)
Humans , Male , Female , Aged , Middle Aged , Adult , Glucose Intolerance , Insulin Resistance , Non-alcoholic Fatty Liver Disease , Hyperinsulinism , Prediabetic State , Insulin-Secreting Cells , Insulins , Glucose , LipidsABSTRACT
INTRODUCTION: In the management of type 2 diabetes, insulin is often started late, when there is failure to achieve good control on maximum oral agents. Clinical inertia to insulin initiation and intensification is widely prevalent in our local setting resulting in poor control of diabetes. This study looked into a stepwise insulin combinations treatment algorithm used in an Endocrinology referral clinic at the University of Santo Tomas Hospital (USTH). It aimed to demonstrate the clinical course of the patients , determine the degree of HbA1c reduction, and show the associated extent of hypoglycemia and weight gain. METHODS: This is a retrospective chart review of 104 patients that used the following stepwise treatment: Oral regimen; Regimen A: basal+oral; Regimen B: basal+premeal bolus TID±oral; Regimen C: premixed aspart 70/30 or lispro 75/25 TID or BID with prelunch bolus, ± oral; Regimen D: premixed 70/30 BID+premeal bolus TID ± oral; Regimen E: premixed 70/30 BI +premeal bolus TID+basal ±oral. All received automatic snacking two hours after main meals to prevent hypoglycemia. Patients were educated on proper diet and exercise. Data was analyzed using paired t-test, frequencies and percentages. RESULTS: Most ended on the intensive insulin regimens D 57(55%), and E 18 (17%). Significant HbA1c reduction was demonstrated as follows: Regimen A (n=8):1.376±0.919 (p=0.000), Regimen B (n=18):2.320±2.177 (p=0.000), Regimen D (n=57):2.197±2.158 (p=0.000), Regimen E (n=18):2.684±1.689 (p =0.000). Overall mean weight gain was 1.070 ± 11.435 kg (p=0.335). Ten, nonsevere hypoglycemia events were reported. CONCLUSION: The use of this stepwise insulin combinations treatment algorithm exerted significant HbA1c reduction, with minimal events of hypoglycemia, and statistically insignificant weight gain. Hence, this is a feasible tool that may be used as a guide for intensification of insulin treatment.
Subject(s)
Humans , Male , Female , Aged , Middle Aged , Adult , Insulin Lispro , Insulin , Diabetes Mellitus, Type 2 , Weight Gain , Hypoglycemia , Antineoplastic Combined Chemotherapy Protocols , Diet , AlgorithmsABSTRACT
INTRODUCTION: Postprandial lipemia characterized by a rise in triglyceride-rich lipoproteins after eating, is associated with increased risk of cardiovascular disease. Among diabetic patients, postprandial lipemia is often overlooked once fasting lipid parameters are within target. The aim of the study is to determine the correlation of glycemic control and postprandial hyperglycemia with postprandial lipemia among patients with type 2 diabetes mellitus (DM). The result of the study may have important implications on how dyslipidemia should be completely addressed. METHODOLOGY: A clinic-based retrospective chart review of 102 patients with recorded fasting and postprandial blood measurements was performed. Subjects included adult patients with type 2 DM whose fasting lipid parameters were controlled with diet and/or medications. Plasma glucose and glycosylated hemoglobin (HbA1C) were independent variables while triglyceride, total cholesterol, low density lipoprotein (LDL) and high density lipoprotein (HDL) were dependent variables. Pearson correlation was used to determine the strength of relationships among the variables mentioned. A p-value RESULTS: Of the 102 patients, 52.9% and 47.1% were achieving their target HbA1C and twohour postprandial plasma glucose, respectively. The postprandial level of plasma glucose, mean triglyceride, total cholesterol, LDL and HDL were 196.39 mg/dL, 189.06 mg/dL, 177.07 mg/dL, 122.40 mg/dL and 34.83 mg/dL, respectively. HbA1C has strong positive correlation with postprandial lipemia (Pearson's r=0.40) while the two-hour plasma glucose has moderate positive correlation (Pearson's r=0.34) with postprandial lipemia. Both relationships were considered significant (p-value CONCLUSION: A significant correlation of glycemic control and postprandial hyperglycemia with postprandial lipemia was observed. Our data suggest that despite achievement of optimal fasting lipid parameters, poor control of diabetes is positively correlated with abnormal elevation of postprandial triglyceride. Addressing both postprandial hyperglycemia and lipemia may improve cardiovascular outcome.
Subject(s)
Humans , Male , Female , Aged , Middle Aged , Adult , Glycated Hemoglobin , Diabetes Mellitus, Type 2 , Lipoproteins , Hyperlipidemias , Dyslipidemias , Hyperglycemia , Cholesterol , Cardiovascular DiseasesABSTRACT
INTRODUCTION:Radioactive iodine(I131) therapy is an established definitive treatment for Graves' hyperthyroidism.However,the optimal method of determining the radioiodine treatment dose remains controversial.OBJECTIVE: To compare the efficacy of fixed dose versus calculated dose regimen in the treatment of Graves' hyperthyroidism among Filipinos METHODOLOGY: Diagnosed Graves' disease patients underwent thyroid ultrasound to estimate thyroid size. Patients were randomized to either fixed or calculated dose of radioiodine treatment. For fixed dose group,the WHO goiter grading was utilized: Grade 0 (5mCi), Grade 1 (7mCi), Grade2 (10mCi), Grade 3 (15mCi). For calculated dose group the following formula was used: Dose(mCi)= 160uCi/g thyroid x thyroid gland weight in grams x 100 / 24-hour RAIU(%)Thyroid function test (TSH,FT4) was monitored every three months for one year. RESULTS: Of the 60 patients enrolled, 45 (fixed dose; n= 27, calculated dose; n= 18) completed the six months follow-up study. Analysis was done by application of the intention-to-treat principle. The percentage failure rate at third month in the fixed vs. calculated dose group was: 26 v. 28% with a relative risk (RR) value of 0.93. At six months post-therapy, there was a noted reduction in the failure rates for both study groups (11 vs. 22%, respectively), with a further reduction in the relative risk value (0.67), favoring the fixed dose group.CONCLUSION: Fixed dose radioiodine therapy for Graves' disease is observed to have a lower risk of treatment failure (persistent hyperthyroidism) at three and six months post-therapy compared to the calculated dose.
Subject(s)
Humans , Male , Female , Middle Aged , Adult , Iodine Radioisotopes , Iodine , Intention to Treat Analysis , Graves Disease , Hyperthyroidism , Goiter , Thyroid Function Tests , Treatment FailureABSTRACT
OBJECTIVE: To establish data determining the etiology of hypopituitarism in the University of Santo Tomas Hospital (USTH) and to describe the clinical and biochemical profile of these patients.METHODOLOGY: A retrospective descriptive study in a tertiary hospital (USTH) involving patients diagnosed by clinical evaluation and biochemical tests to have hypopituitarism, admitted or seen at the outpatient department from January 2001 to December 2009 and whose charts were available for review. The clinical profile, manifestations and biochemical profile were defined and causes of hypopituitarism identified. Descriptive statistics were applied using percentages and frequency distribution.RESULTS: In the nine-year period (2001-2009), a total of 191 patients were recorded to have hypopituitarism but only 143 (75%) have adequate data available for review. Sixty one (43%) were males and 82 (51%) were females with mean age was 45±6 years. Hypopituitarism was found to be most prevalent in the fourth to fifth decade of life and clinical manifestations were noted with mean duration of 20±4 months. The most predominant documented pituitary hormone deficiency was gonadotrophic hormone (60%) manifesting prominently as decreased libido (82%). The most common target end organ hormone deficiency was secondary adrenal insufficiency (90%) and most prevalent etiology of hypopituitarism was pituitary tumors (40%). Sheehan's syndrome (8%) and tuberculosis (3%) were also noted as a cause of hypopituitarism.CONCLUSION: This study shows that the leading clinical manifestation and documented hormone deficiency of hypopituitarism is hypogonadism. Pituitary adenoma is the most common cause of hypopituitarism along with its treatment. Other causes not commonly seen in other countries but proved to be more prevalent here include Sheehan's syndrome and tuberculosis infection.